Prevalence of cancer and the benign call rate of afirma gene classifier in 18F‐Fluorodeoxyglucose positron emission tomography positive cytologically indeterminate thyroid nodules

Prevalence of cancer and the benign call rate of afirma gene classifier in 18F‐Fluorodeoxyglucose positron emission tomography positive cytologically indeterminate thyroid nodules

Abstract Background 18 F‐Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) positive (PET+) cytologically indeterminate thyroid nodules (ITNs) have variable cancer risk in the literature. The benign call rate (BCR) of Afirma Gene Classifier (Gene Expression Classifier...

Full description

Bibliographic Details
Main Authors: Mayumi Endo, Jennifer A. Sipos, Matthew D. Ringel, Kyle Porter, Haikady N. Nagaraja, John E. Phay, Lawrence A. Shirley, Clarine Long, Chadwick L. Wright, Katie Roll, Fadi A. Nabhan
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Cancer Medicine
Subjects:
18Fluorine‐fluorodeoxyglucose
afirma
positron emission tomography
Thyroid Nodules
Online Access:https://doi.org/10.1002/cam4.3704

Internet

https://doi.org/10.1002/cam4.3704

Similar Items